Skip to main content
RNA Biology logoLink to RNA Biology
. 2016 Jun 28;13(9):756–759. doi: 10.1080/15476286.2016.1201628

m6A: Signaling for mRNA splicing

Samir Adhikari a, Wen Xiao a, Yong-Liang Zhao b, Yun-Gui Yang a
PMCID: PMC5013988  PMID: 27351695

ABSTRACT

Among myriads of distinct chemical modifications in RNAs, dynamic N6-methyladenosine (m6A) is one of the most prevalent modifications in eukaryotic mRNAs and non-coding RNAs. Similar to the critical role of chemical modifications in regulation of DNA and protein activities, RNA m6A modification is also observed to be involved in the regulation of diverse functions of RNAs including meiosis, fertility, development, cell reprogramming and circadian period. The RNA m6A modification is recognized by YTH domain containing family proteins comprising of YTHDC1-2 and YTHDF1-3. Here we focus on the nuclear m6A reader YTHDC1 and its regulatory role in alternative splicing and other RNA metabolic processes.

KEYWORDS: Alternative splicing, m6A, SRSF3, SRSF10, YTHDC1


There are more than 100 distinct chemical modifications in RNAs and one third of such modifications comprise the addition of methyl groups to the RNA base. Among them, N6-methyladenosine (m6A) modification is the most prevalent one.1 The advance of high throughput sequencing technology has enabled us to identify the location and distribution of RNA modifications at single base resolution. RNA m6A methylation occurs at the N-6 position of the adenosine residue in the consensus motif of RRACH (R represents purine and H is either A, C or U) catalyzed by METTL3 and METTL14 heterodimer.2 WTAP and KIAA1429 serve as regulatory factors in this process.3,4 The occurrence of RNA m6A modification is highly selective despite of abundant RRACH motif along the RNA. Moreover, m6A is particularly enriched in the 3′ untranslated regions (UTRs) and within internal exons, suggesting their evolutionarily conserved significance.5-7 This modification is reversed by demethylases FTO and ALKBH5 demonstrating the reversible and dynamic nature of m6A modification.8,9 FTO was discovered as the first RNA m6A demethylase in year of 2011 followed by the identification of another m6A demethylase ALKBH5 in 2013. Since then, a number of studies have defined the landscape and significance of RNA m6A methylome, which largely advances the RNA field.

The biological function of dynamic RNA m6A modification is also mediated by another class of proteins capable of recognizing m6A, such as YTHDC1. YTHDC1 localizes in the nuclear compartment called YT bodies adjacent to nuclear speckle, the site for RNA processing.10 Recent studies illustrate that RNA m6A modification serves as mark for the recruitment of splicing factors and then affects alternative splicing (AS) events. YTHDC1 has been reported to affect AS patterns in a concentration dependent manner but the underlying mechanism remains unclear.11 Here we shed light on the mechanism of how m6A and its reader YTHDC1 coordinately regulate AS events in mammalian systems.

YTHDC1 and other m6A readers

YTHDC1 (also known as YT521-B) is the founding member of YTH (YT521-B homology) domain containing protein family. YTH domain-containing family proteins were initially identified as single stranded RNA binding proteins through YTH domain at the C terminus. YTH domain contains 100–150 amino acid residues capable of binding short, degenerated, single-stranded RNA sequence motif.12 Biochemical and biophysical investigations have shown that the aromatic cage formed by tryptophan residues are critical for the recognition of m6A in RNA by YTH domain containing proteins.13 Humans have 5 YTH domain containing proteins named YTHDC1–2, and YTHDF1–3.

YTHDC1 is nuclear m6A reader reported to bind to m6A through its tryptophan residues at 377 and 428 positions by forming aromatic cage.14 The amino-terminal glutamic acid rich region and the carboxyl-terminal glutamic acid/arginine rich-region of YTHDC1 are critical in its nuclear localization where it involves YT body formation.11 Phosphorylation of YTHDC1 by src kinases c-src and p59fyn affects its solubility and distribution in the YT body leading to its diffusion in the nucleoplasm and disruption of its dynamic interactions with pre-mRNA protein complexes.15 Owing to the proximity of YT bodies to nuclear speckle, it is possible that YTHDC1 gets access to nascently transcribed pre-mRNA facilitating the recruitment of other YTHDC1-associated splicing factors.

YTHDF1, YTHDF2 and YTHDF3 are cytoplasmic m6A readers.14 YTHDF1 has been shown to promote translation by interacting with the translation machinery where it can selectively recognize the m6A modified RNAs from the pool of RNAs and facilitate their loading on to the ribosome.16 YTHDF2 has been shown to regulate the stability of cytoplasmic mRNAs by targeting them to RNA decay site, such as processing bodies, and is also implicated in promoting translation initiation of selective transcripts by interacting with the translation initiation factors under heat shock stress.17,18

There are several additional factors that have been shown to serve as the m6A readers. HNRNPA2B1 binds to the consensus m6A modified site both in vivo and in vitro. Upon binding to m6A, HNRNPA2B1 regulates AS events in a subset of its targeted RNAs and miRNA processing in a m6A-dependent manner, however, the underlying mechanism needs further investigation.19 ELAVL1, a ubiquitously expressed RNA stabilizer, also serves as a potential m6A reader identified by m6A containing RNA bait.5 ELAVL1/HUR binding to m6A occurs only when its binding motif is adjacent to m6A, and meanwhile this binding is spatiotemporally regulated. METTL3/METTL14-mediated m6A modification in developmental regulator-associated RNA transcripts has been shown to interfere the m6A binding of ELAVL1/HUR leading to destabilization of the target transcripts.20 eIF3 is another m6A reader, and the findings from in vivo and in vitro experiments revealed that eIF3 facilitates recruitment of 43S preinitiation complex to 5′ UTR of mRNA and promotes translation through selectively binding to m6A residues in 5′UTR.21

Alternative splicing regulated by m6A reader YTHDC1

Alternative splicing, the process producing multiple mRNA variants from a single gene transcript and ultimately diversifying the mammalian proteome, was discovered along with splicing.22,23 Almost 95% of human genes undergo AS allowing them exert different regulatory functions from chromatin modification to signal transduction.24 AS is regulated in a tissue specific way with striking variations depending on developmental or differentiation cues. Many factors such as protein regulators (trans-acting splicing factors) and RNA sequence elements (cis-regulatory elements) play a coordinated role in AS regulation.25 m6A-dependent AS regulation is a well-observed phenomenon.5,6 This is supported by our previous studies showing that methyltransferase METTL3, its regulator WTAP and m6A demethylases FTO and ALKBH5 all influence alternative splicing.3,9,26 Here we will discuss the potential significance of ubiquitous RNA m6A modification in AS regulation through its nuclear reader YTHDC1.

Nuclear m6A reader YTHDC1 has been implicated in the regulation of splicing by maintaining a dynamic interaction network of different family of proteins. In our recent study by Xiao et al,27 we found that YTHDC1 interacts with splicing factors SRSF1, SRSF3, SRSF7, SRSF9, and SRSF10, suggesting its potential role in the course of pre-mRNA splicing. Analysis of AS event using RNA-seq following percent spliced in (PSI) technique revealed that YTHDC1 and SRSF3 promote exon inclusion, whereas SRSF10 facilitates exon skipping. SRSF1, SRSF7 and SRSF9 failed to show any significant effect on the splicing pattern of their bound targets, indicating that they may function in other aspects of RNA metabolism. We investigated the AS change patterns of the representative target genes by RT-PCR analysis and found that YTHDC1/SRSF3 and SRSF10 differentially regulate the splicing in a m6A-dependent manner, which is supported by the observation that the binding regions of YTHDC1, SRSF3 and SRSF10 were significantly enriched in coding sequences and 3′UTR, in agreement with the m6A distribution pattern. Moreover, YTHDC1 clusters showed a significant enrichment in the longer exons with enriched m6A modifications, indicating a preferential regulation of AS in longer exons by YTHDC1. Depletion of RNA m6A methyltransferase METTL3 had a similar effect on the splicing of the target exons as that of YTHDC1/SRSF3 depletion suggesting a m6A-dependent splicing regulation.

Comprehensive analysis of m6A distribution along the mRNA revealed that m6A peaks do not significantly coincide with exon-exon junctions. As such, m6A may not directly influence the mRNA binding of the splicing factors.6 We found a significant representation of binding clusters of YTHDC1, SRSF3 and SRSF10 in exonic regions near splicing sites. Additionally, the motif enriched in YTHDC1 binding clusters coincided well with m6A consensus motif of RRACH, whereas the motifs in SRSF3 and SRSF10 binding clusters were not fully consistent with m6A motif even though they were quite similar to a significant extent. Also it was revealed that both SRSF3 and SRSF10 binding motifs are in a close proximity with the binding region of YTHDC1, however, SRSF3 binding motif is closer to YTHDC1 binding region than that of SRSF10. These findings provide a logical explanation that YTHDC1 modulates the recruitment of these factors to their target motifs in a m6A-dependent manner, and at the same time creates spatial competing relationship favoring binding of either SRSF3 or SRSF10 only to its target RNA. This was further validated by the observation that both SRSF3 and SRSF10 interact directly with N-terminal of YTHDC1 through their RS domain located at the carboxy terminus, and YTHDC1 is competitively bound by SRSF3 and SRSF10. The competitive binding of SRSF3 and SRSF10 to YTHDC1 provides a plausible explanation for the antagonistic effect of SRSF3 and SRSF10 on inclusion of target exons, and therefore, provides a novel regulatory mechanism for cells to favor required exon inclusion/skipping event. The interaction of YTHDC1 with SRSF3 may sequester YTHDC1 leading to the decrease of its availability for interaction with SRSF10 and consequently predominant recruitment of SRSF3 to its target site. It is also likely that the in vivo interaction of YTHDC1 and SRSF10 may induce their conformational changes masking their own RNA-binding motifs consequently blocking the binding of YTHDC1 and SRSF10 complex to their target sites.

YTHDC1 forms YT bodies adjacent to nuclear speckle supporting the assumption of its involvement in the regulation of splicing. We found that YTHDC1 not only interacts with SRSF3 and SRSF10 but also regulates the patterns of their nuclear speckle localization in a m6A-dependent manner. YTHDC1 promotes SRSF3 but inhibits SRSF10 in their nuclear speckle staining. Additionally, SRSF10 nuclear speckle staining pattern was diminished by SRSF3 and vice versa. Interestingly, the antagonistic effect of YTHDC1 on the regulation of nuclear speckle-staining patterns of SRSF3 and SRSF10 is m6A-dependent. These observations provide further evidence that the differential splicing outcomes regulated by YTHDC1 are in a m6A dependent manner.

The observations that SRSF3 and SRSF10 competitively bind to YTHDC1 and YTHDC1/SRSF3 antagonize SRSF10 in the regulation of both nuclear speckle staining and AS events suggested that YTHDC1 is involved in the regulation of RNA binding ability of SRSF3 and SRSF10. This was further proved by PAR-CLIP (photoactivatable ribonucleoside crosslinking and immunoprecipitation) in combination with RNA 3′ end biotin-labeling assay. We found that YTHDC1 indeed affects the RNA binding ability of its interactors SRSF3 and SRSF10. YTHDC1 enhances SRSF3 but inhibits SRSF10 in their RNA binding ability. Consistent with the antagonistic effect of SRSF3 and SRSF10 on their own nuclear speckle staining pattern, a similar role in RNA binding ability was also observed between them. Interestingly, SRSF10 inhibited the RNA binding ability of YTHDC1 whereas SRSF3 did not show such effect.

The presence of RNA m6A modification was found to be critical in the regulation of RNA binding ability of YTHDC1, SRSF3 and SRSF10, as evidenced by the PAR-CLIP experiments in control and METTL3 knockdown conditions. Our findings strongly support the assumption that YTHDC1 first binds to m6A modification and then recruits SRSF3 to its binding motif of its target RNA. This also explains how the competitive binding of YTHDC1 by SRSF3 and SRSF10 influences their RNA binding ability and hence leads to differential splicing outcomes. Since SRSF3 is more abundant than SRSF10, it is likely that under normal physiological condition, formation of SRSF3-YTHDC1 complex is dominant preferably favoring exon inclusion. Moreover, the effect of YTHDC1 on the RNA binding ability of SRSF3 and SRSF10 and further AS depends on its binding ability to m6A modification.

These discoveries provided substantial evidence regarding the significance of RNA m6A modification and its reader YTHDC1 in the regulation of AS through differentially modulating the RNA binding ability of splicing factors SRSF3 and SRSF10.

Future perspective

m6A as the most prevalent modification on mRNAs has long been identified but significant advances were only gained after the discovery of m6A demethylase FTO followed by the identification of another m6A demethylase ALKBH5 together with the invention of improved m6A detection approach. These studies concurred that RNA m6A modification is a reversible mark and has a significant role in the regulation of gene expression.5,6,8,9 The next generation sequencing of m6A containing RNAs immunoprecipitated by m6A antibody revealed the presence of m6A in thousands of mRNA and hundreds of non-coding RNA (ncRNA) transcripts.5,6 Given the significant enrichment of m6A in 3′ UTR, it is likely that m6A could affect the mRNAs targeted by miRNA and many RNA binding proteins with preferentially binding to m6A-modified regions. Further Investigations shall decipher the significance of m6A modification in 3′UTR. The distribution of m6A along the 5′ UTR has been implicated in the translational control but the underlying mechanism needs to be clarified.18 m6A modifications are also enriched in the intronic region, providing another possibility that the process of intron removal and then gene expression by recruiting splicing factors may be influenced or regulated. RNA m6A modification is also the most prevalent modification found in various different types of transcripts ranging from microRNAs to long noncoding RNAs, suggesting that m6A may also regulate ncRNA processing via its readers including YTHDC1.27 m6A has been shown to modulates the local structure of coding and non-coding transcripts and hence regulate RNA-HNRNPC interaction affecting gene expression.28 This suggests the role of prevalent m6A modification in gene expression regulation through structural remodeling of RNAs influencing their interaction with RNA binding proteins. So far only a handful of mRNA m6A readers are identified and have been implicated in splicing, stability and translation.5,13,15-20,26 Given the ubiquitous nature of m6A modification throughout different types of transcripts, there shall be more m6A binding proteins that are worthy of further investigation. Identification of such readers and further elucidation of their effect on the RNA metabolism will definitely expand our current understanding of the potential significance of m6A modification.

Disclosure of potential confllicts of interest

No potential conflicts of interest were disclosed.

Funding

This work was supported by NSFC31430022, CAS Strategic Priority Research Program XDB14030300 and CAS Precision Medicine Initiative KJZD-EW-L14.

References

  • 1.Motorin Y, Helm M. RNA nucleotide methylation. Wiley Interdiscip Rev RNA; 2011; 2:611-31; PMID:21823225; http://dx.doi.org/ 10.1002/wrna.79 [DOI] [PubMed] [Google Scholar]
  • 2.Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, Jia G, Yu M, Lu Z, Deng X, et al.. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol 2013; 10:93-5; PMID:24316715; http://dx.doi.org/ 10.1038/nchembio.1432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ping X-L, Sun B-F, Wang L, Xiao W, Yang X, Wang W-J, Adhikari S, Shi Y, Lv Y, Chen Y-S, et al.. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res 2014; 24:177-89; PMID:24407421; http://dx.doi.org/ 10.1038/cr.2014.3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Schwartz S, Mumbach MR, Jovanovic M, Wang T, Maciag K, Bushkin GG, Mertins P, Ter-Ovanesyan D, Habib N, Cacchiarelli D, et al.. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep 2014; 8:284-96; PMID:24981863; http://dx.doi.org/ 10.1016/j.celrep.2014.05.048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, et al.. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 2012; 485:201-6; PMID:22575960; http://dx.doi.org/ 10.1038/nature11112 [DOI] [PubMed] [Google Scholar]
  • 6.Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 2012; 149:1635-46; PMID:22608085; http://dx.doi.org/ 10.1016/j.cell.2012.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Ke S, Alemu EA, Mertens C, Gantman EC, Fak JJ, Mele A, Haripal B, Zucker-Scharff I, Moore MJ, Park CY, et al.. A majority of m6A residues are in the last exons, allowing the potential for 3′ UTR regulation. Genes Dev 2015; 29:2037-53; PMID:26404942; http://dx.doi.org/ 10.1101/gad.269415.115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang Y-G, et al.. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 2011; 7:885-7; PMID:22002720; http://dx.doi.org/ 10.1038/nchembio.687 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang C-M, Li CJ, Vågbø CB, Shi Y, Wang W-L, Song S-H, et al.. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol Cell 2013; 49:18-29; PMID:23177736; http://dx.doi.org/ 10.1016/j.molcel.2012.10.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nayler O, Hartmann AM, Stamm S. The ER repeat protein YT521-B localizes to a novel subnuclear compartment. J Cell Biol 2000; 150:949-62; PMID:10973987; http://dx.doi.org/ 10.1083/jcb.150.5.949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hartmann AM, Nayler O, Schwaiger FW, Obermeier A, Stamm S. The interaction and colocalization of Sam68 with the splicing-associated factor YT521-B in nuclear dots is regulated by the Src family kinase p59fyn. Mol Biol Cell 1999; 10:3909-26; PMID:10564280; http://dx.doi.org/ 10.1091/mbc.10.11.3909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhang Z, Theler D, Kaminska KH, Hiller M, de la Grange P, Pudimat R, Rafalska I, Heinrich B, Bujnicki JM, Allain FHT, et al.. The YTH domain is a novel RNA binding domain. J Biol Chem 2010; 285:14701-10; PMID:20167602; http://dx.doi.org/ 10.1074/jbc.M110.104711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zhu T, Roundtree IA, Wang P, Wang X, Wang L, Sun C, Tian Y, Li J, He C, Xu Y. Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine. Cell Res 2014; 24:1493-6; PMID:25412661; http://dx.doi.org/ 10.1038/cr.2014.152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Xu C, Wang X, Liu K, Roundtree IA, Tempel W, Li Y, Lu Z, He C, Min J. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol 2014; 10:927-9; PMID:25242552; http://dx.doi.org/ 10.1038/nchembio.1654 [DOI] [PubMed] [Google Scholar]
  • 15.Rafalska I. The intranuclear localization and function of YT521-B is regulated by tyrosine phosphorylation. Hum Mol Genet 2004; 13:1535-49; PMID:15175272; http://dx.doi.org/ 10.1093/hmg/ddh167 [DOI] [PubMed] [Google Scholar]
  • 16.Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C. N6-methyladenosine modulates messenger RNA translation efficiency. Cell 2015; 161:1388-99; PMID:26046440; http://dx.doi.org/ 10.1016/j.cell.2015.05.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, et al.. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 2013; 505:117-20; PMID:24284625; http://dx.doi.org/ 10.1038/nature12730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian S-B. Dynamic m6A mRNA methylation directs translational control of heat shock response. Nature 2015; 526:591-4; PMID:26458103; http://dx.doi.org/ 10.1038/nature15377 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Alarcón CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF. HNRNPA2B1 is a mediator of m6A-dependent nuclear RNA processing events. Cell 2015; 162:1299-308; PMID:26321680; http://dx.doi.org/ 10.1016/j.cell.2015.08.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells. Nat Cell Biol 2014; 16:191-8; PMID:24394384; http://dx.doi.org/ 10.1038/ncb2902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Meyer KD, Patil DP, Zhou J, Zinoviev A, Skabkin MA, Elemento O, Pestova TV, Qian S-B, Jaffrey SR. Five′ UTR m6A promotes cap-independent translation. Cell 2015; 163:999-1010; PMID:26593424; http://dx.doi.org/ 10.1016/j.cell.2015.10.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chow LT, Gelinas RE, Broker TR, Roberts RJ. An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 1977; 12:1-8; PMID:902310; http://dx.doi.org/ 10.1016/0092-8674(77)90180-5 [DOI] [PubMed] [Google Scholar]
  • 23.Nilsen TW, Graveley BR. Expansion of the eukaryotic proteome by alternative splicing. Nature 2010; 463:457-63; PMID:20110989; http://dx.doi.org/ 10.1038/nature08909 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008; 40:1413-5; PMID:18978789; http://dx.doi.org/ 10.1038/ng.259 [DOI] [PubMed] [Google Scholar]
  • 25.Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10:741-54; PMID:19773805; http://dx.doi.org/ 10.1038/nrm2777 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Zhao X, Yang Y, Sun B-F, Shi Y, Yang X, Xiao W, Hao Y-J, Ping X-L, Chen Y-S, Wang W-J, et al.. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis. Cell Res 2014; 24:1403-19; PMID:25412662; http://dx.doi.org/ 10.1038/cr.2014.151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Xiao W, Adhikari S, Dahal U, Chen Y-S, Hao Y-J, Sun B-F, Sun H-Y, Li A, Ping X-L, Lai W-Y, et al.. Nuclear m6A reader YTHDC1 regulates mRNA splicing. Mol Cell 2016; 61:507-19; PMID:26876937; http://dx.doi.org/ 10.1016/j.molcel.2016.01.012 [DOI] [PubMed] [Google Scholar]
  • 28.Liu N, Dai Q, Zheng G, He C, Parisien M, Pan T. N6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactions. Nature 2015; 518:560-4; PMID:25719671; http://dx.doi.org/ 10.1038/nature14234 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from RNA Biology are provided here courtesy of Taylor & Francis

RESOURCES